Hostname: page-component-788cddb947-55tpx Total loading time: 0 Render date: 2024-10-13T19:08:53.001Z Has data issue: false hasContentIssue false

GLUCOSE TRANSPORT INHIBITORS PROTECT AGAINST 1,2-CYCLOHEXANEDIONE-PRODUCED POTASSIUM LOSS FROM HUMAN RED BLOOD CELLS

Published online by Cambridge University Press:  30 August 2019

G. F. BAKER
Affiliation:
Department of Biological Sciences, Royal Holloway, University of London, Egham, Surrey TW20 0EX, UK
R. O'GORMAN
Affiliation:
Department of Biological Sciences, Royal Holloway, University of London, Egham, Surrey TW20 0EX, UK
P. BAKER
Affiliation:
Department of Biological Sciences, Royal Holloway, University of London, Egham, Surrey TW20 0EX, UK
Get access

Abstract

It has been suggested that the glucose transport system of human erythrocytes contains an arginine shield to prevent the leak of potassium through the transporter. To investigate this suggestion we treated human erythrocytes with the specific arginine reagent 1,2-cyclohexanedione. Under conditions which produce a covalent reaction between arginine and the reagent, a steady leak of potassium occurs. If glucose, maltose or the inhibitor phloretin are present during the reaction the extent of the leak is reduced. These findings support the view that arginines have a role in preventing potassium loss through the glucose transporter.

Type
Physiological Society Symposium
Copyright
The Physiological Society 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)